It has been said before - based on very sticky and recurring sales - their revenue could be view more as ARR and treated accordingly.
- Forums
- ASX - By Stock
- BIO
- Ann: Q1 FY25 Revenue Guidance
Ann: Q1 FY25 Revenue Guidance, page-39
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIO (ASX) to my watchlist
(20min delay)
|
|||||
Last
67.5¢ |
Change
-0.015(2.17%) |
Mkt cap ! $147.9M |
Open | High | Low | Value | Volume |
69.0¢ | 70.5¢ | 67.0¢ | $154.8K | 228.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7307 | 67.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
68.5¢ | 3701 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7307 | 0.675 |
2 | 41294 | 0.670 |
2 | 5201 | 0.665 |
12 | 76999 | 0.660 |
2 | 24550 | 0.655 |
Price($) | Vol. | No. |
---|---|---|
0.685 | 3701 | 1 |
0.690 | 3701 | 1 |
0.695 | 3701 | 1 |
0.700 | 38230 | 2 |
0.705 | 7367 | 1 |
Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
Featured News
BIO (ASX) Chart |